We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · January 31, 2023

New Prognostic Model in Patients With Advanced Urothelial Carcinoma Treated With Second-Line ICIs

Journal for immunotherapy of cancer


Additional Info

Journal for immunotherapy of cancer
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
J Immunother Cancer 2023 Jan 01;11(1)e005977, A Bamias, A Merseburger, Y Loriot, N James, E Choy, D Castellano, F Lopez-Rios, F Calabrò, M Kramer, G de Velasco, R Zakopoulou, K Tzannis, CN Sternberg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading